November 3, 2025 November 3, 2025Categories EditorialsBeating the odds: Steven Merlin’s journey through pancreatic cancer and clinical trialsAn inspiring interview with a 13-year survivor of stage 4 pancreas cancer
November 3, 2025 November 3, 2025Categories Ongoing TrialsOngoing Trials: A closer look at ECOG-ACRIN’s clinical trials for patients with pancreatic conditionsFor Pancreatic Cancer Awareness Month, we highlight two actively recruiting clinical trials for patients with pancreatic conditions
May 19, 2025 May 19, 2025Categories Trial ResultsTop trial results of 2024: A year of major progress in cancer treatmentSeven ground-breaking findings from cancer clinical trials in 2024 by ECOG-ACRIN and PrECOG
July 2, 2024 July 2, 2024Categories Trial ResultsECOG-ACRIN research round-up – Summer 2024Takeaways from ECOG-ACRIN trial results presented at the 2024 American Society of Clinical Oncology Annual Meeting
March 23, 2023 March 23, 2023Categories Ongoing TrialsVideo: Advocates discuss the EA2185 research study for patients with pancreatic cystsWatch cancer research advocates Lisa Beckendorf and Steven Merlin discuss the EA2185 study for patients with pancreatic cysts
June 28, 2022 June 28, 2022Categories Trial ResultsTrial Results: ECOG-ACRIN research round-up – Summer 2022Summaries of recently reported ECOG-ACRIN research results
September 20, 2021 September 20, 2021Categories New TrialsNow Enrolling: The APOLLO clinical trial is studying an additional treatment option after standard therapy for certain patients with pancreatic cancerThis study is for patients with pancreatic cancer that has been surgically removed and has a BRCA1, BRCA2, or PALB2 mutation